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The influenza A virus RNA-dependent RNA polymerase produces capped and polyadenylated
mRNAs in the nucleus of infected cells that resemble mature cellular mRNAs, but are made by
very different mechanisms. Furthermore, only two of the 10 viral protein-coding mRNAs are
spliced: most are intronless, while two contain unremoved introns. The mechanism(s) by which
any of these mRNAs are exported from the nucleus is uncertain. To probe the involvement of the
primary cellular mRNA export pathway, we treated cells with siRNAs against NXF1, Aly or UAP56,
or with the drug 5,6-dichloro-1-b-D-ribofuranosyl-benzimidazole (DRB), an inhibitor of RNA
polymerase II phosphorylation previously shown to inhibit nuclear export of cellular mRNA as well
as influenza virus segment 7 mRNAs. Depletion of NXF1 or DRB treatment had similar effects,
inhibiting the nuclear export of several of the viral mRNAs. However, differing degrees of sensitivity
were seen, depending on the particular segment examined. Intronless HA mRNA and spliced M2
or unspliced M1 transcripts (all encoding late proteins) showed a strong requirement for NXF1,
while intronless early gene mRNAs, especially NP mRNA, showed the least dependency.
Depletion of Aly had little effect on viral mRNA export, but reduction of UAP56 levels strongly
inhibited trafficking and/or translation of the M1, M2 and NS1 mRNAs. Synthesis of NS2 from the
spliced segment 8 transcript was, however, resistant. We conclude that influenza A virus co-opts
the main cellular mRNA export pathway for a subset of its mRNAs, including most but not all late
gene transcripts.
INTRODUCTION
Influenza A virus has a negative-sense RNA genome split
into eight viral (v) RNA segments. Unusually for an RNA
virus without a DNA-encoding stage, vRNA synthesis
occurs in the nucleus (Amorim & Digard, 2006). Here, the
vRNAs are transcribed by the viral RNA-dependent RNA
polymerase to produce 10 major species of capped and
polyadenylated mRNA. Although these transcripts are
structurally similar to mature host mRNAs, their terminal
modifications are achieved through mechanistically dis-
tinct routes. Viral mRNAs contain 59-cap structures that
are synthesized by the cellular capping machinery but
recycled through the process of ‘cap-snatching’, in which a
cap-dependent endonuclease activity in the viral polymer-
ase generates capped oligonucleotide primers from cellular
pre-mRNAs (Neumann et al., 2004). Poly(A) tails are
synthesized by the viral polymerase stuttering on a poly(U)
tract near the 59-end of each vRNA segment (Neumann
et al., 2004), rather than by the host 39-end processing
machinery and poly(A) polymerase. The maturation
pathway of most of the viral transcripts also differs from
that of cellular mRNAs. While the majority of cellular
pre-mRNAs contain introns that are completely removed
before nuclear export, most influenza mRNAs (those
from segments 1–6, encoding PB2, PB1, PA, HA, NP and
NA, respectively, in their largest ORFs) are intronless.
Furthermore, although segments 7 and 8 contain introns,
the majority (~90%) of the primary transcripts are ex-
ported unspliced to produce the abundant M1 and NS1
polypeptides, respectively, while the processed minority
encode the M2 and NS2/NEP proteins (Lamb & Horvath,
1991). Thus, the 10 protein-coding influenza virus mRNAs
can be classified into three structural classes: intronless,
intron-containing but unspliced and fully spliced. Viral
mRNAs can also be subdivided into ‘early’ (segments 1–3,
5 and the unspliced segment 8 transcript) and ‘late’
(segments 4, 6, 7 and spliced segment 8) classes, based on
the temporal expression patterns of their protein products
(Hatada et al., 1989; Inglis & Mahy, 1979; Lamb et al.,
1978; Skehel, 1972). However, these structural or kinetic
classifications do not neatly correspond.
The mechanism(s) by which influenza virus mRNAs reach
the cytoplasm is unclear. Cellular mRNAs are predomi-
nantly exported in the form of messenger ribonucleopro-
tein complexes (mRNPs) via the NXF1/TAP pathway.
Formation and recruitment of these mRNPs to the NXF1
Journal of General Virology (2010), 91, 1290–1301 DOI 10.1099/vir.0.018564-0
1290 018564 G 2010 SGM Printed in Great Britainexport pathway is closely coupled to Pol II transcription
and pre-mRNA maturation, including capping, splicing
and polyadenylation steps (Erkmann & Kutay, 2004;
Fasken & Corbett, 2005; Howe, 2002). During synthesis
and processing, a cellular mRNA dynamically acquires a
complex set of proteins, including various heterogeneous
nuclear ribonucleoproteins (hnRNPs), poly(A)-binding
proteins and the transcription-export (TREX) complex.
TREX, consisting of the THO complex, UAP56 (BAT1)
and Aly (REF/THOC4), is primarily recruited to the pre-
mRNA during splicing (Masuda et al., 2005; Strasser et al.,
2002) but also through interactions with the 59-cap
structure (Cheng et al., 2006; Nojima et al., 2007). Aly
then recruits NXF1 and its co-factor p15, which displaces
Aly and allows NXF1/p15 to bind the RNA directly
(Hautbergue et al., 2008). NXF1–p15 interactions with
the nuclear pore complex then direct export of the mRNP
into the cytoplasm. The synthesis of influenza mRNAs by a
viral polymerase and the fact that most are either intronless
or contain residual introns raises the question of how,
or even if, they are fed into the NXF1 pathway. Alterna-
tive cellular mRNA export pathways exist, the best cha-
racterized of which utilizes the CRM1/exportin 1 factor
(Carmody & Wente, 2009; Hutten & Kehlenbach, 2007).
Other nuclear replicating viruses such as herpesviruses
manage to export intronless mRNAs by encoding adaptor
proteins that functionally replace Aly and link the viral
transcripts to the NXF1 pathway (Boyne et al., 2008;
Stamminger, 2008). Retroviruses export intron-containing
mRNAs through cis-acting RNA sequences that (directly or
via a viral adaptor protein) recruit either NXF1- or CRM1-
dependent pathways (Cullen, 2003; Fontoura et al., 2005).
Indirect evidence argues both for and against influenza
virus possessing analogous mechanisms. Viral gene expres-
sion is insensitive to leptomycin B (LMB) treatment (Elton
et al., 2001), as is the export of mRNAs from segments 6
and 7 (Amorim et al., 2007; Wang et al., 2008), arguing
against the use of the CRM1 pathway. However, drugs that
inhibit Pol II lead to reversible nuclear retention of
segment 4 and 7 but not segment 5 mRNAs (Amorim
et al., 2007; Vogel et al., 1994). Transcription-dependent
export of cellular mRNA has also been demonstrated
(Huang et al., 1994; Tokunaga et al., 2006), suggesting that
at least some influenza mRNAs use cellular export
machinery that is ordinarily coupled to Pol II transcription.
Consistent with this, an siRNA screen for proteins involved
in the early stages of influenza virus replication in
Drosophila cells identified NXF1 as important for expres-
sion of a chimaeric reporter gene based on segment 6, as
well as for overall virus replication in mammalian cells
(Hao et al., 2008). It has also been shown that influenza
mRNAs from segments 2, 6 and 7 interact with NXF1
(Wang et al., 2008). However, a direct test of whether
NXF1 functions in the export of any or all the influenza
virus mRNAs has not been reported. Furthermore, it has
also been proposed that influenza virus NS1 antagonizes
the export function of NXF1 as a means of contributing to
host-cell shut off (Satterly et al., 2007).
Accordingly, to clarify the mechanism(s) by which
influenza A virus mRNAs are exported from the nucleus,
we set out to directly test the involvement of the cellular
NXF1 and CRM1 pathways. We found no evidence for the
involvement of the latter system in influenza mRNA
export, whereas export of all viral transcripts tested showed
some degree of sensitivity to NXF1 levels. However, a
gradient of dependence was evident, with late gene mRNAs
being the most sensitive and the intronless early gene
transcripts being the least sensitive.
RESULTS
Previously, we showed that inhibition of RNA Pol II
transcription blocked the nuclear export of segment 7
mRNAs (encoding M1/M2), but not segment 5 (NP)
mRNA (Amorim et al., 2007). Analysis of viral protein
expression in the presence of the drug 5,6-dichloro-1-b-D-
ribofuranosyl-benzimidazole (DRB), an inhibitor of pro-
cessive Pol II elongation (Clement & Wilkinson, 2000;
Fraser et al., 1978; Tamm et al., 1980), showed reductions
in the synthesis of HA and NS1 which suggested that
ongoing Pol II transcription was necessary for the export
of other viral mRNAs than just that encoding M1
(Amorim et al., 2007). However, the processing and
export of cellular pre-mRNAs is also associated with the
nuclear loading of protein factors that subsequently
upregulate translation of the mature transcripts in the
cytoplasm (Fasken & Corbett, 2005; Howe, 2002). We
therefore tested directly whether DRB treatment inhibited
export of other influenza virus mRNAs than those from
segment 7. Cells were infected (or mock infected) with
influenza A/PR/8/34 (PR8) virus and 90 min post-
infection (p.i.) were either treated with DRB or left
untreated.At 6.5 h p.i., thecells werefixed andanalysed by
fluorescence in situ hybridization (FISH) for the local-
ization of positive-sense RNA from segments 1, 4, 5, 7 and
8. Only background levels of signal were seen from
uninfected cells (Fig. 1a). In untreated cells all of the viral
mRNAs tested were found to be predominantly cytoplas-
mic (Fig. 1b). When infected cells were treated with DRB,
segment 5 mRNA still remained mostly cytoplasmic, while
as expected (Amorim et al., 2007) segment 7 transcripts
showed pronounced nuclear retention (Fig. 1c). Segment 4
mRNA (encoding HA) also showed almost total nuclear
retention after DRB treatment, while transcripts from
segments 1 (PB2) and 8 (NS1/NS2) showed an inter-
mediate phenotype with obvious nuclear retention, but
with residual cytoplasmic staining still clearly visible
(Fig. 1c). Thus, nuclear export of the majority of influ-
enza mRNAs is sensitive to DRB treatment and the loss of
NS1 and HA protein expression under these conditions
(Amorim et al., 2007; Tamm et al., 1984) directly reflects
reduced nuclear export of their mRNAs. However, a
gradient of responsiveness to the inhibitor was apparent,
with the transcripts of early genes generally showing
reduced sensitivity than those of late genes.
Influenza A virus mRNA export
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both influenza and cellular mRNA export (Amorim et al.,
2007; Huang et al., 1994; Tokunaga et al., 2006), it was
reasonable to hypothesize that the cellular mRNA export
machinery was involved. Accordingly, we targeted key
components of the cellular bulk mRNA export machinery:
NXF1, Aly and UAP56, for siRNA-mediated knockdown.
We also targeted hnRNPA1, a protein involved in cellular
mRNP biogenesis, as well as glyceraldehyde-3-phosphate
dehydrogenase (GAPD) as a control for non-specific
siRNA effects. Both UAP56 and hnRNPA1 have been
identified as interaction partners of influenza A virus NP/
RNPs (Mayer et al., 2007; Momose et al., 2001). Lysates
from siRNA-treated human embryonic kidney (293T)
cells were first analysed by Western blotting to confirm
successful knockdown of the target proteins. In all cases,
a reduction in the levels of the targeted protein in
comparison with control or untreated cells was apparent
(Fig. 2a). When blots from replicate experiments were
quantified, normalized to actin levels and compared with
untreated cells, NXF1 levels were reduced by 75, Aly by 60,
UAP56 by 80 and hnRNPA1 by 90% at 48 h post-
transfection (Fig. 2b), confirming successful reductions in
expression.
To establish whether depletion of these cellular proteins
affected influenza virus replication, siRNA-treated cells
were infected with PR8 virus and the output titres
determined by plaque assay. The effect of DRB on virus
replication was also assessed, as a known inhibitor of
Fig. 1. Effect of DRB on influenza virus mRNA localization. 293T cells were infected (or mock infected) with PR8 virus, treated
where indicated with DRB at 90 min and 6.5 h p.i. localization of the indicated segments determined by FISH (red) and wide
field fluorescence microscopy. Nuclei were counterstained with DAPI and false-coloured blue.
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blocking viral mRNA export and/or gene expression
(Amorim et al., 2007; Tamm et al., 1984); this treatment
reduced virus titres by around 50-fold compared with
untreated cells (Fig. 2c). Cells in which GAPD had been
targeted for knockdown showed only a slight reduction in
their ability to replicate virus, as did cells depleted of
hnRNPA1 or Aly (Fig. 2c). However, targeting of NXF1
reduced the output virus titre approximately 100-fold,
while knockdown of UAP56 reduced replication by nearly
10-fold (Fig. 2c). These data, consistent with a previous
study that examined knockdown of NXF1 (Hao et al.,
2008), strongly suggested that NXF1 was involved in
influenza replication, while UAP56 may also be important.
To better define the role of these cellular proteins in the
influenza virus life cycle, we next examined viral protein
expression in siRNA-treated cells. Lysates from cells treated
with siRNAs (or later treated with DRB as a positive
control) and then infected with virus were analysed by
Western blotting for a panel of viral proteins, including the
early class gene products PB2 (as a representative
polymerase protein), NP and NS1, the late proteins HA
and M1 and the two products of spliced mRNAs, M2 and
NS2. RT-PCR analysis of the relative abundance of the M1
and M2 mRNAs indicated that none of the siRNA
treatments had a major effect on splicing of segment 7
transcripts (data not shown). The levels of cellular actin
were also examined to ensure equal quantities of cell lysate
had been tested (Fig. 3a, bottom row). Viral proteins were
readily detectable in samples from untreated infected cells,
but not in mock infected cell lysates (Fig. 3a, lanes 7 and 8).
As observed previously (Amorim et al., 2007; Tamm et al.,
1984), DRB treatment profoundly decreased levels of the
late viral proteins M1 and HA and reduced NS1 and M2
synthesis, while leaving NP and NS2 accumulation
unaffected (Fig. 3a, lane 6). The partial retention of
segment 1 mRNA seen after DRB treatment (Fig. 1)
correlated with a threefold reduction in PB2 accumulation
(Fig. 3a, lane 6; see Fig. 3b for quantification). When viral
protein levels were examined in siRNA-treated cells,
depletion of GAPD or hnRNPA1 had no effect (Fig. 3a,
lanes 4 and 5; quantification in Fig. 3b). Depletion of Aly
also had little consequence for viral protein levels, causing
at the most a twofold reduction in M2 accumulation (Fig.
3a, lane 2). Knockdown of UAP56 had more effect; while
PB2, NP and NS2 levels were unaffected, NS1, HA, M1 and
M2 accumulation were all reduced by threefold or more,
with M2 being the most severely affected (Fig. 3a, lane 3
and Fig. 3b). However, consistent with its effect on virus
titre, depletion of NXF1 had the greatest effect on viral
gene expression, severely reducing M2 and HA protein
levels and also reducing M1, NS1 and NS2 accumulation by
around threefold. Similarly to DRB treatment, NXF1
depletion had little effect on NP accumulation, while PB2
levels were also unaffected.
Thus, reduced quantities of certain components of the
cellular mRNA export machinery leads to much reduced
synthesis of particular influenza virus proteins. The most
obvious cause for this would be inhibition of viral mRNA
export. To test this we infected siRNA-treated cells and
analysed the localization of viral mRNA by FISH. Positive-
sense transcripts from segments 1, 4, 5, 7 and 8 were all
largely cytoplasmic in cells treated with siRNAs targeting
GAPD (Fig. 4a), similar to the pattern seen in untreated
cells (Fig. 1b). This pattern was not altered by siRNA
depletion of either hnRNPA1 or Aly (Fig. 4e, c, res-
pectively). Quantification of the nuclear:cytoplasmic ratio
of staining intensity seen for the FISH probes from
multiple cells confirmed that there was no substantial
change in localization of any of the viral transcripts
examined (Fig. 5). Depletion of UAP56 also had little effect
on the localization of mRNAs from segments 1, 4 and 5,
either by visual inspection (Fig. 4d) or by quantification of
fluorescence intensity (Fig. 5). However, substantial
nuclear retention was obvious for mRNAs from segments
7 and 8 (Fig. 4d), resulting in between 8 and nearly 30-fold
increases in the relative amount of nuclear staining (Fig. 5).
Depletion of NXF1 caused a similarly large decrease in the
amount of cytoplasmic mRNA from segments 7 and 8,
but pronounced nuclear retention of segment 4 was
also apparent (Figs 4b and 5). A slight (around twofold)
increase in nuclear:cytoplasmic staining ratios was also
seen for segment 1 and 5 mRNAs. Thus, UAP56 is required
for the export of segment 7 and 8 mRNAs, while NXF1 is
Fig. 2. siRNA depletion of cellular mRNA export factors. (a, b)
Lysates from infected siRNA-treated or mock-treated 293T cells at
6.5 h p.i. were analysed by SDS-PAGE and Western blotting for
the indicated antigens. (b) Levels of the indicated polypeptides
from replicate experiments were quantified and plotted as the
mean±SEM relative to untreated cells. (c) siRNA-treated cells were
infected at an m.o.i. of 10 and output virus titres at 11 h p.i. from
cells treated (or mock treated) with siRNAs targeting the indicated
proteins determined by plaque assay. The mean±SD of three
independent experiments is shown.
Influenza A virus mRNA export
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A virus mRNAs, but to a degree that depends on the
specific transcript examined. Also, the similar effects DRB
treatment and NXF1 depletion have on viral mRNA
localization coupled with previous work showing that
DRB treatment inhibits bulk cellular mRNA export
(Huang et al., 1994; Tokunaga et al., 2006) suggests that
the drug inhibits NXF1-dependent mRNA export.
The low sensitivity of intronless early gene transcripts to
the effects of NXF1 depletion or DRB treatment could
result from their use of a non-NXF1-dependent export
pathway. Alternatively, these mRNAs might still use NXF1
but recruit it via a different, more efficient mechanism than
that used by the late gene/spliced transcripts, which largely
bypasses the blocks introduced by DRB or gene silencing.
As a first test of these possibilities, we examined whether
influenza virus mRNA export was sensitive to LMB, as
CRM1 is the best delineated alternative pathway for mRNA
nuclear export (Carmody & Wente, 2009; Hutten &
Kehlenbach, 2007). Madin–Darby canine kidney (MDCK)
cells were infected with virus, treated (or mock treated)
with LMB from 1.5 h p.i. and viral mRNA localization
examined by FISH. Parallel analysis of the intracellular
localization of NP showed its LMB-dependent nuclear
retention as expected (Elton et al., 2001), confirming
activity of the drug (data not shown). Again, positive-sense
transcripts from segments 1, 4, 5 and 7 were largely
detected in the cytoplasm in untreated cells (Fig. 6, middle
panels). Also consistent with previous results (Amorim
et al., 2007; Wang et al., 2008), localization of mRNA from
segment 7 was unaltered by LMB treatment (Fig. 6, lower
right). Moreover, trafficking of segment 1, 4 and 5
transcripts were also unaffected by the drug. Similar results
were obtained in 293T and BHK cells (data not shown).
Thus, while not eliminating the hypothesis that the early
intronless viral mRNAs utilize a non-NXF1-dependent
export pathway, these data indicate that they do not use a
CRM1-dependent mechanism.
DISCUSSION
Like any virus that transcribes its genome in the nucleus of
infected cells, influenza A must ensure that its mRNAs
reach the cytoplasm. Retroviruses and nuclear-replicating
Fig. 3. Effect of siRNA depletion of cellular mRNA export factors on viral gene expression (a, b) 293T cells were transfected
with siRNAs against the indicated proteins [or mock transfected (–)] then infected or mock infected with virus. Cell lysates taken
at 6.5 h p.i. were analysed by Western blotting for the indicated antigens. (b) Accumulation of the indicated viral polypeptides
from replicate experiments were quantified and plotted as the mean±SEM of the level seen in non-siRNA-treated infected cells
after normalization for actin levels.
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perhaps rendered more difficult by an RNA genome and
consequent use of a virally encoded RNA-dependent RNA
polymerase. We show here that despite not directly using
Pol II to transcribe its genome, influenza virus nevertheless
co-opts the cellular NXF1 export machinery for at least a
subset of its mRNAs. We also show that not all viral
mRNAs interact equally with this nuclear export pathway,
with individual viral transcripts displaying a gradient of
susceptibility to treatments that disrupt bulk mRNA
export. Differing requirements for the helicase UAP56
were also seen. These data allow us to start building a
model for how the individual viral mRNAs reach the
cytoplasm (Fig. 7).
Our conclusion that the NXF1 pathway is used for
influenza virus mRNA export is based on several strands
of evidence. Firstly, it is supported by prior work showing
that NXF1 is required for viral replication (Hao et al.,
2008) and that mRNAs from segments 2, 6 and 7 can be
co-immunoprecipitated with NXF1 (Wang et al., 2008).
More directly, however, we show for the first time that loss
of cellular NXF1 strongly inhibited nuclear export of
segment 4, 7 and 8 mRNAs (Figs 4b and 5). The FISH
probes we employed do not discriminate between spliced
and unspliced transcripts from the latter two vRNAs, but
synthesis of all four polypeptides encoded by the segments
were reduced (Fig. 3), suggesting that export of the
minority spliced species (especially that of M2) was also
Fig. 4. Effect of siRNA depletion of cellular mRNA export factors on viral mRNA localization. 293T cells were transfected with
siRNAs against the labelled proteins, infected with virus and positive-sense transcripts from the indicated segments detected
by FISH followed by confocal microscopy.
Influenza A virus mRNA export
http://vir.sgmjournals.org 1295inhibited. Transport of segment 4, 7 and 8 mRNAs, as well
as expression of the proteins they encode (excepting NS2),
were also strongly retarded by the Pol II inhibitor, DRB
(Figs 1 and 3). In contrast, the nucleo-cytoplasmic
distribution of the intronless mRNAs from segments 1
and 5 were relatively unaffected by NXF1 depletion,
displaying only a twofold change (Fig. 5) without a
matching reduction in accumulation of the translation
products (Fig. 3b). DRB also had little effect on NP mRNA
localization or translation, while partial nuclear retention
of segment 1 mRNA was seen, only a threefold drop in
protein accumulation resulted (Figs 1 and 3b).
The selective nature of the defects in viral gene expression
arising from NXF1 or UAP56 depletion also argue that the
requirement for the cellular export machinery is direct
(and not simply the consequence of lowered cell viability),
since the siRNA-treated cells were still readily infectable
with virus and able to support normal synthesis of certain
viral polypeptides. This is also consistent with the findings
of Hao et al. (2008) who found that NXF1 depletion of
HEK cells did not dramatically affect cell viability over the
time-spans used here.
The differing susceptibilities individual viral mRNAs
showed to siRNA depletion of cellular export factors or
DRB correlated better with the kinetic class of the viral
gene product than with mRNA structure. Intronless
transcripts for early gene products (in particular segment
5/NP mRNA) but also segment 1 (PB2) showed the least
dependence on the NXF1 pathway (Fig. 7a), while late
genes, including the intronless mRNA encoding HA, the
spliced mRNA for M2 and the intron-containing but
unspliced M1 message showing the clearest dependence
(Fig. 7b–d). We have not examined the susceptibility of
segment 6 (NA) mRNA to NXF1 depletion but Wang et al.
(2008) showed an association between the two molecules,
while Hao et al. (2008) reported that NXF1 depletion
blocked expression of an artificial reporter mRNA based
on segment 6. It therefore seems plausible that the NA
mRNA has a similar export mechanism to the HA mRNA
(Fig. 7b). The correlation between the degree of depend-
ence on NXF1 and the kinetic class of the viral gene
product is not perfect however, as expression of the late
protein NS2 (from the spliced segment 8 mRNA) was less
sensitive to DRB than expression of the early protein NS1
from the unspliced transcript (Fig. 3b) and the export of
the majority population of positive-sense mRNA from
segment 8 was inhibited by both DRB and NXF1 depletion
(Figs 1, 4 and 5).
The question therefore arises of how the viral mRNAs are
recruited to the NXF1/p15 pathway for export. Depletion
of Aly, the most thoroughly characterized adaptor protein
for cellular mRNA, had little effect on transport of viral
messages (Figs 4 and 5) or protein expression (Fig. 3). This
is perhaps surprising given the dependence cellular mRNAs
show on Aly for export (Carmody & Wente, 2009; Cheng
et al., 2006; Nojima et al., 2007), but we saw no more than
a twofold drop in M2 levels (Fig. 3). We were only able to
knockdown Aly expression by ~60% however (Fig. 2) and
although control experiments examining the localization of
polyadenylated mRNAs in uninfected siRNA-treated cells
showed a degree of nuclear retention (data not shown), it
may be that more efficient depletion would reveal a more
marked phenotype. Alternatively, our data may indicate a
more important role for other cellular adaptor proteins,
such as the recently described UIF protein (Hautbergue
et al., 2009). A strong requirement for UAP56, another
component of the TREX complex and responsible for
recruiting Aly to cellular pre-mRNAs, was however seen
for export and/or expression of certain viral messages
(Fig. 7c, d). UAP56 depletion caused marked retention of
segment 7 and 8 transcripts and concomitant reductions in
M1, M2 and NS1 expression (Figs 3, 4 and 5). Curiously,
however, NS2 expression was resistant to UAP56 deple-
tion, further highlighting that individual viral trans-
cripts show significant differences in their interactions
with the cellular export machinery, even when considering
the two spliced mRNAs. Also of note was the finding that
while UAP56 depletion had little effect on segment 4
localization, (producing less than a twofold increase in the
nuclear:cytoplasmic ratio of segment 4 mRNA), a more
than threefold reduction in protein expression was seen
(Figs 3 and 5). Loss of functional UAP56 has been shown
to affect the transport of mRNA within the cytoplasm
of Drosophila oocytes (Meignin & Davis, 2008), so we
speculate that the reduction in HA expression seen here
results from an effect downstream of mRNA nuclear
export.
Fig. 5. Quantitative analysis of the effect of siRNA depletion of
cellular mRNA export factors on viral mRNA localization. The
nuclear:cytoplasmic staining ratios of the FISH probes from
replicate confocal FISH images of infected cells treated with
siRNAs as described in Fig. 4 were determined and plotted as the
fold change compared with the values seen in GAPD siRNA-
treated cells. Error bars represent the SEM.
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are required for export of certain viral transcripts, the
mechanism(s) by which these factors are recruited to the
mRNAs remains to be determined. Maturation of M2
mRNA resembles that of a normal cellular pre-mRNA:
intron removal presumably leads to deposition of the
exon junction complex, including UAP56, which will
then recruit Aly and NXF1 (Fig. 7d). Alternatively or in
addition, NXF1 might be directly recruited to the serine/
arginine-rich protein splicing factor 2/alternative splic-
ing factor (SF2/ASF) (Huang et al., 2003) as the latter
polypeptide has been shown to regulate the extent of
segment 7 splicing (Shih & Krug, 1996a). Recruitment of
UAP56 and NXF1 to the unspliced transcripts as well as
NXF1 to the intronless late genes is less obvious. UAP56
can be directed to unstructured regions of intronless
mRNAs, although if this mechanism applied to the
influenza virus transcripts more dependence on Aly
might have been expected (Taniguchi & Ohno, 2008).
Alternatively, the 59-cap structure of mRNA plays an
important role in the export of both spliced and
intronless cellular mRNAs, via the cap-binding complex
(CBC) recruiting Aly and thus NXF1 (Cheng et al., 2006;
Nojima et al., 2007). However, the CBC must be
displaced from the 59-cap of cellular pre-mRNAs by the
viral polymerase during the process of cap-snatching
and although PB2 releases the mRNA cap early after
transcription initiation (Braam et al., 1983), it is not
known whether the CBC rebinds to mature viral mRNAs.
Arguing against quick re-recruitment of the CBC, splic-
ing of segment 7 mRNA is controlled by the viral poly-
merase binding to the 59-end of the mRNA (including
the cap structure as well as an internal polymerase-
binding sequence) thereby blocking the 59-most splice
donor site (Fig. 7d; Shih et al., 1995). It has also been
proposed that the 59-ends of all viral mRNAs are simi-
larly occupied by the viral polymerase as a mechanism to
prevent a futile cycle of utilizing viral mRNAs as cap-
donors (Shih & Krug, 1996b), but this proposal has not
been tested in vivo yet.
Fig. 6. Effect of LMB treatment on viral mRNA localization. MDCK cells were infected or mock infected with virus, treated
where indicated with LMB from 90 min p.i. and positive-sense RNA from specific segments (as labelled) detected by FISH and
confocal microscopy at 6.5 h p.i.
Influenza A virus mRNA export
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transcribing viruses (Schneider & Wolff, 2009) it is also
possible that viral polypeptide(s) act as an adaptor between
the viral mRNA and the cellular nuclear export pathway.
For instance, it has been suggested that the viral
polymerase complex might functionally replace the cellular
CBC for the purposes of nuclear export (Shih & Krug,
1996b). It is well established that the viral polymerase
interacts with Pol II (Engelhardt et al., 2005; Loucaides
et al., 2009; Mayer et al., 2007; Rameix-Welti et al., 2009),
potentially placing it in the correct local environment to
interact with the export machinery that would normally
be recruited co-transcriptionally to a cellular pre-mRNA.
Such a mechanism is compatible with the observation
that drugs that inhibit Pol II transcription inhibit export
of most of the viral mRNAs (Amorim et al., 2007; Vogel
et al., 1994; Wang et al., 2008; this study). NP is also
a plausible adaptor candidate: non-RNP-associated NP
shuttles between nucleus and cytoplasm (Elton et al., 2001;
Neumann et al., 1997; Whittaker et al., 1996) as well as
interacting with several cellular proteins involved in mRNA
biogenesis and trafficking (Josset et al., 2008; Mayer et al.,
2007; Momose et al., 2001). While our data here do not
support a functionally important role for the NP–
hnRNPA1 interaction, they are consistent with (although
not proof of) a role for the NP–UAP56 interaction in viral
mRNA trafficking. Similarly, circumstantial evidence sug-
gests NS1 might also function as an export adaptor
(Schneider & Wolff, 2009). It interacts with NXF1 and
other components of the mRNA export pathway (Satterly
et al., 2007) as well as with at least a subset of the viral
mRNAs (Wang et al., 2008). However, the near normal
export of the NP and PB2 mRNAs seen after NXF1
depletion or DRB treatment when NS1 expression is much
reduced, as well as a consideration of the kinetics of protein
expression in normal cells suggests that if this mechanism
Fig. 7. Cartoon model for influenza virus mRNA export. Viral mRNAs split into the four indicated conceptual classes are
synthesized in the nucleus by vRNPs. (a) Intronless mRNAs encoding early gene products (PB2, NP, putatively PB1 and PA)
show only weak dependence on NXF1 levels for nuclear export. If NXF1 is directly involved in their export, its means of
recruitment are unknown. (b) Intronless mRNAs encoding late gene products (HA, probably NA) show strong dependence on
NXF1 for export, but its means of recruitment is also uncertain. (c) Unspliced, intron containing mRNAs (M1 and NS1) show
strong dependence on NXF1 and UAP56 levels for export. (d) Spliced segment 7 mRNA (M2) shows strong dependence on
NXF1 and UAP56 levels and a weak dependence on Aly for its export, which is proposed to follow the normal cellular pattern of
splicing dependent deposition of the exon junction complex followed by recruitment of UAP56, Aly and NXF1. The viral
polymerase complex (3P) is also known to bind the 59-end of this mRNA and may also interact with other viral mRNAs. NS2
mRNA is omitted from this model because of insufficient data.
E. K. C. Read and P. Digard
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gene transcripts.
METHODS
Materials. 293T and MDCK cells were cultured as described
previously (Hutchinson et al., 2008). PR8 virus was grown in cells
in serum-free medium in the presence of 1 mg trypsin ml
21 and
0.14% BSA and titrated by plaque assay in MDCK cells as described
previously (Hutchinson et al., 2008). Virus infections were performed
at an m.o.i. of 10. DRB (Calbiochem) was used at 150 mM and LMB
(LC Laboratories) at 10 nM. Rabbit anti-NP, anti-M1, anti-PR8 (HA)
and anti-PB2 sera have been described previously (Amorim et al.,
2007; Noton et al., 2007). Anti-NS2 serum was the kind gift of
Dr Agustin Portela (Agencia Espan ˜ola del Medicamento, 28220
Madrid, Spain). Anti-M2 (clone 14C2), anti-Aly (11G5), anti-UAP56
(ab47955), anti-GAPD (6C5), anti-hnRNPA1 (9H10), anti-NXF1
(53H8) and anti-actin (mAbcam8226) were purchased from Abcam.
Secondary antibodies were purchased from Molecular Probes, LiCor
Biosciences or DAKO. Plasmids pCDNA-PB2, pCDNA-HA, pCDNA-
NP, pCDNA-M1 and pCB82 contain cDNA copies of PR8 segments
1, 4, 5, 7 and 8 (Amorim et al., 2007; Carrasco et al., 2004; Harman
et al., 2002; Mullin et al., 2004). siPool siRNAs were purchased from
Dharmacon. 293T cells were plated at 0.5610
5 cell per well 1 day
prior to transfection then transfected with 100 nM siRNA (final
concentration) by using Dharmafect-1 following the manufacturer’s
instructions.
Microscopy. FISH was performed essentially as described previously
(Amorim et al., 2007). To synthesize mRNA-binding probes, plasmid
templates were linearized with HindIII for pCDNA-M1, XbaI for
pCB82 and KpnI for pCDNA-PB2, -NP or -HA, and transcribed
using SP6 RNA polymerase in the presence of 0.15 mM cyanine
3-UTP (Perkin Elmer) or 25 mM Dig-UTP (Roche). Fluorescence
images were captured using a Leica TCS-NT confocal microscope or
an Olympus IX70 fluorescence microscope fitted with a Retiga 2000R
camera. Post-capture processing was carried out using Adobe
Photoshop to apply linear brightness/contrast adjustments evenly
across figure panels.
To quantify mRNA nuclear:cytoplasmic ratios, confocal images were
analysed using the program ImageJ (NIH). DAPI counterstaining was
used to identify the nucleus, which was manually defined using the
region of interest (ROI) manager. The cell periphery was also
manually delineated using the ROI manager. Nuclear and total
cellular intensities for the FISH probe were quantified by using the
measure function and the cytoplasmic reading taken as (total-
nuclear) intensities. The average intensity of the two compartments
was then calculated and used to generate a nuclear:cytoplasmic
staining ratio.
Protein analyses. Cell lysates were analysed by SDS-PAGE and
Western blotting according to standard procedures. Blots were
imaged by chemiluminescence by using horseradish-peroxidase-
conjugated secondary antibodies and X-ray film, or (for quantifica-
tion) by fluorescence using IRDye 700/800-conjugated secondary
antibodies on a Licor Biosciences Odyssey near-infrared imaging
platform. Protein levels were quantified using Licor Odyssey version 3
software using background correction followed by normalization to
an actin loading control.
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